معرفی
Professor Alan C. Spivey holds the position of Professor of Synthetic Chemistry at Imperial College London's Department of Chemistry within the Faculty of Natural Sciences. He is currently serving as Associate Provost (Learning and Teaching). His academic journey includes roles at the University of Sheffield and research fellowships at Geneva and Cambridge Universities. Spivey's research focuses on developing synthetic methodologies and applying them to biologically significant molecules, including asthma and cancer therapeutics, agrochemicals, and imaging agents.
Education: BSc (1st Class) in Chemistry from the University of Nottingham (1985–1988), DPhil in Organic Chemistry under Sir Jack Baldwin at Oxford (1988–1991). Postdoctoral work with Oppolzer (Geneva) and Battersby (Cambridge). Professional affiliations include FRSC, CChem, CSci, and memberships in ACS, SFEHA, and FSB.
Research Interests: Asymmetric synthesis, Ge-chemistry, natural product total synthesis, IgE-FceRI antagonists, LRH-1 nuclear receptor modulators, and nitric oxide-protein interactions. Collaborations span institutions like King’s College London, University College London, and industry partners such as AstraZeneca and Novartis.
Recent Publications Highlight Trends in: EGFR PET imaging agents, IgE receptor antagonists, and LRH-1 cancer therapeutics. His work bridges organic synthesis with biomedical applications, emphasizing method development for drug discovery.
Awards: Not explicitly listed in the provided texts, but contributions to synthetic chemistry and medicinal research are notable.
Advising and Grants: Led Imperial’s undergraduate chemistry programs and held leadership roles in education committees. Research funded by EPSRC, MRC, Wellcome Trust, CRUK, and industry partnerships.
Labs and Teams: Spivey Group collaborates with multiple labs, including the Membrane Receptor Network and the Institute of Chemical Biology. Affiliated with initiatives like the CDT in Chemical Biology and the Agri Futures Lab.
